Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127132742 | 12713274 | 2 | F | 20130913 | 20160831 | 20160902 | 20160908 | EXP | JP-ASTRAZENECA-2016SE91612 | ASTRAZENECA | 67.00 | YR | M | Y | 0.00000 | 20160909 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127132742 | 12713274 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 560 | MG | Y | 21153 | 20 | MG | CAPSULE | QD | ||||
| 127132742 | 12713274 | 2 | SS | CRAVIT | LEVOFLOXACIN | 1 | Oral | 60.0MG UNKNOWN | Y | 0 | 60 | MG | TABLET | ||||||
| 127132742 | 12713274 | 3 | SS | CRAVIT | LEVOFLOXACIN | 1 | Oral | DOSE UNKNOWN UNKNOWN | Y | 0 | TABLET | ||||||||
| 127132742 | 12713274 | 4 | SS | LOXOPROFEN | LOXOPROFEN | 1 | Oral | 20 MG DAILY, AS REQUIRED | Y | 0 | TABLET | ||||||||
| 127132742 | 12713274 | 5 | C | SULPERAZON | CEFOPERAZONE SODIUMSULBACTAM SODIUM | 1 | Unknown | DOSE UNKNOWN | 0 | ||||||||||
| 127132742 | 12713274 | 6 | C | SULPERAZON | CEFOPERAZONE SODIUMSULBACTAM SODIUM | 1 | Unknown | DOSE UNKNOWN | 0 | ||||||||||
| 127132742 | 12713274 | 7 | C | URSO | URSODIOL | 1 | Unknown | DOSE UNKNOWN | 0 | ||||||||||
| 127132742 | 12713274 | 8 | C | KLARICID | CLARITHROMYCIN | 1 | Unknown | DOSE UNKNOWN | 0 | ||||||||||
| 127132742 | 12713274 | 9 | C | MUCOSOLVAN | AMBROXOL HYDROCHLORIDE | 1 | Unknown | DOSE UNKNOWN | 0 | ||||||||||
| 127132742 | 12713274 | 10 | C | VITAMEDIN | CYANOCOBALAMINPYRIDOXINE HYDROCHLORIDETHIAMINE | 1 | Unknown | DOSE UNKNOWN | 0 | ||||||||||
| 127132742 | 12713274 | 11 | C | BFLUID | AMINO ACIDSDEXTROSEELECTROLYTES NOSVITAMINS | 1 | Unknown | DOSE UNKNOWN | 0 | ||||||||||
| 127132742 | 12713274 | 12 | C | MERISLON | BETAHISTINE MESILATE | 1 | Unknown | DOSE UNKNOWN | 0 | ||||||||||
| 127132742 | 12713274 | 13 | C | CLARITIN | LORATADINE | 1 | Unknown | DOSE UNKNOWN | 0 | ||||||||||
| 127132742 | 12713274 | 14 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | Unknown | DOSE UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127132742 | 12713274 | 8 | Sputum retention |
| 127132742 | 12713274 | 9 | Sputum retention |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127132742 | 12713274 | LT |
| 127132742 | 12713274 | OT |
| 127132742 | 12713274 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127132742 | 12713274 | Cholangitis | |
| 127132742 | 12713274 | Disease progression | |
| 127132742 | 12713274 | Klebsiella bacteraemia | |
| 127132742 | 12713274 | Renal failure | |
| 127132742 | 12713274 | Septic shock | |
| 127132742 | 12713274 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127132742 | 12713274 | 1 | 20130822 | 20130918 | 0 | |
| 127132742 | 12713274 | 2 | 20130919 | 20130924 | 0 | |
| 127132742 | 12713274 | 3 | 20130927 | 20131003 | 0 | |
| 127132742 | 12713274 | 4 | 20130913 | 20131007 | 0 | |
| 127132742 | 12713274 | 5 | 20130823 | 0 | ||
| 127132742 | 12713274 | 6 | 20130913 | 20130918 | 0 | |
| 127132742 | 12713274 | 7 | 20130824 | 20131003 | 0 | |
| 127132742 | 12713274 | 8 | 20130917 | 0 | ||
| 127132742 | 12713274 | 9 | 20130917 | 0 |